SCR-LIP-000426 · Claim · machine-readable JSON →
This narrative hypothesis-generating review references lipedema staging (e.g., the transition from Stage 2.5 to Stage 3) while proposing inflammatory myosteatosis as a mechanistic link between lipedema progression and dynapenia, without testing or evaluating diagnostic or staging criteria.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-08-16 → 2026-08-16
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-08-16
Evidence over time
Evidence (1)
- Lipedema and Dynapenia: Inflammatory Myosteatosis as a (2026) ✓ verified — contextual · review · 2026 · reading confidence: high
“particularly during the transition from Stage 2.5 to Stage 3”
The review mentions lipedema stages in passing to frame its pathophysiological hypothesis about muscle dysfunction, but does not describe, evaluate, or assess the reliability of diagnostic or staging classification systems; hence it is on-t
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-08-16 — created · auto-ingested for SQ-LIP-000022